Literature DB >> 17498524

Carcinoid heart disease.

Alain M Bernheim1, Heidi M Connolly, Timothy J Hobday, Martin D Abel, Patricia A Pellikka.   

Abstract

Carcinoid heart disease is a rare form of valvular heart disease. The management of these patients is complex, as the systemic malignant disease and the cardiac involvement have to be considered at the same time. Progress in the treatment of patients with carcinoid disease has resulted in improved symptom control and survival. Development and progression of carcinoid heart disease are associated with increased morbidity and mortality. In patients with severe cardiac involvement and well-controlled systemic disease, cardiac surgery has been recognized as the only effective treatment option. Valve replacement surgery may not only be beneficial in terms of symptom relief, but may also contribute to the improved survival observed over the past 2 decades in patients with carcinoid heart disease. Early diagnosis and early surgical treatment in appropriately selected patients may provide the best results. In this article, we review the current literature regarding the biology, diagnosis, treatment, and prognosis of carcinoid heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498524     DOI: 10.1016/j.pcad.2006.12.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  15 in total

1.  Cardiac surgery for carcinoid heart disease.

Authors:  Hiroaki Takahashi; Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-12-16

2.  Surgical outcomes of isolated tricuspid valve procedures: repair versus replacement.

Authors:  Julius I Ejiofor; Robert C Neely; Maroun Yammine; Siobhan McGurk; Tsuyoshi Kaneko; Marzia Leacche; Lawrence H Cohn; Prem S Shekar
Journal:  Ann Cardiothorac Surg       Date:  2017-05

Review 3.  Ileal neuroendocrine tumors and heart: not only valvular consequences.

Authors:  Jan Calissendorff; Eva Maret; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2014-10-16       Impact factor: 3.633

4.  Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.

Authors:  Kathryn H Driesbaugh; Emanuela Branchetti; Juan B Grau; Samuel J Keeney; Kimberly Glass; Mark A Oyama; Nancy Rioux; Salma Ayoub; Michael S Sacks; John Quackenbush; Robert J Levy; Giovanni Ferrari
Journal:  J Mol Cell Cardiol       Date:  2017-12-30       Impact factor: 5.000

Review 5.  Carcinoid Heart Disease: a Comprehensive Review.

Authors:  Saamir A Hassan; Nicolas L Palaskas; Ali M Agha; Cezar Iliescu; Juan Lopez-Mattei; Christopher Chen; Henry Zheng; Syed Wamique Yusuf
Journal:  Curr Cardiol Rep       Date:  2019-11-19       Impact factor: 2.931

6.  Carcinoid valve disease.

Authors:  J Wells Askew; Heidi M Connolly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

7.  Bioprosthetic tricuspid valve replacement in carcinoid heart disease from primary ovarian carcinoid tumor.

Authors:  Toshimitsu Tsugu; Shiro Iwanaga; Mitsushige Murata; Keiichi Fukuda
Journal:  J Med Ultrason (2001)       Date:  2015-03-12       Impact factor: 1.314

8.  Ovarian carcinoid presenting with right heart failure.

Authors:  Nikki Damen
Journal:  BMJ Case Rep       Date:  2014-05-28

9.  Metastatic carcinoid tumor presenting as right sided heart failure.

Authors:  Efren Martinez-Quintana; Maria Del Mar Avila-Gonzalez; Laura Suarez-Castellano; Fayna Rodriguez-Gonzalez
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

10.  Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.

Authors:  Walter Noordzij; André P van Beek; René A Tio; Anouk N van der Horst-Schrivers; Elisabeth G de Vries; Bram van Ginkel; Annemiek M Walenkamp; Andor W Glaudemans; Riemer H Slart; Rudi A Dierckx
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.